Hot Pursuit     26-Dec-23
Biocon Ltd soars 1.18%, Gains for third straight session
Biocon Ltd is quoting at Rs 249.2, up 1.18% on the day as on 12:49 IST on the NSE. The stock is down 6.1% in last one year as compared to a 18.18% gain in NIFTY and a 30.28% gain in the Nifty Pharma index.

Biocon Ltd is up for a third straight session in a row. The stock is quoting at Rs 249.2, up 1.18% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is up around 0.37% on the day, quoting at 21428.9. The Sensex is at 71339.72, up 0.33%. Biocon Ltd has added around 6.91% in last one month.

Meanwhile, Nifty Pharma index of which Biocon Ltd is a constituent, has added around 4.02% in last one month and is currently quoting at 16394.35, up 0.88% on the day. The volume in the stock stood at 21.74 lakh shares today, compared to the daily average of 32.46 lakh shares in last one month.

The benchmark December futures contract for the stock is quoting at Rs 249.85, up 1.17% on the day. Biocon Ltd is down 6.1% in last one year as compared to a 18.18% gain in NIFTY and a 30.28% gain in the Nifty Pharma index.

The PE of the stock is 492.4 based on TTM earnings ending September 23.

Previous News
  Biocon gets US FDA nod for fungal infection drug
 ( Hot Pursuit - 04-Jun-24   11:18 )
  Biocon Ltd up for third consecutive session
 ( Hot Pursuit - 01-Dec-23   13:05 )
  Indices edge lower, Nifty near 18,300; breadth positive
 ( Market Commentary - Mid-Session 24-May-23   09:32 )
  Biocon Ltd up for fifth session
 ( Hot Pursuit - 06-Feb-24   13:00 )
  Eris Lifesciences avails term loan of Rs 280 cr from Citi Bank
 ( Corporate News - 09-Nov-23   09:15 )
  Biocon Ltd up for third straight session
 ( Hot Pursuit - 02-Feb-24   13:05 )
  ICICI Bank board to mull fund raising proposal
 ( Hot Pursuit - 20-Apr-24   14:40 )
  Biocon Ltd spurts 4.01%, rises for fifth straight session
 ( Hot Pursuit - 26-Apr-24   13:00 )
  Biocon records PAT of Rs 101 crore in Q1; EBITDA margin at 23%
 ( Hot Pursuit - 11-Aug-23   11:13 )
  Biocon rallies after strong Q4 performance
 ( Hot Pursuit - 24-May-23   09:41 )
  Biocon gets nod from SAHPRA for Tacrolimus capsules
 ( Hot Pursuit - 20-Apr-24   15:36 )
Other Stories
  Dhanlaxmi Bank gains as gross advances rises 6% YoY in Q1 FY25
  05-Jul-24   15:27
  HDFC Bank Ltd leads losers in 'A' group
  05-Jul-24   15:00
  Shilpa Medicare sizzles after Unicycive gets positive results in clinical trials of OLC
  05-Jul-24   14:52
  Manugraph India Ltd leads losers in 'B' group
  05-Jul-24   14:45
  NSE SME Nephro Care India rallies on listing day
  05-Jul-24   14:45
  ESAF SFB total deposits jumps 33% YoY in Q1
  05-Jul-24   14:43
  Utkarsh SFB deposits climb 30% YoY in Q1 FY25
  05-Jul-24   14:35
  Volumes soar at Medplus Health Services Ltd counter
  05-Jul-24   14:30
  Financials stocks slide
  05-Jul-24   14:00
  Banking stocks edge lower
  05-Jul-24   14:00
Back Top